What oral tablet dose of valproic acid (sodium valproate) is equivalent to 10 ml of a liquid formulation containing 250 mg per 5 ml?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Valproic Acid Liquid to Tablet Conversion

10 ml of valproic acid 250 mg/5 ml liquid formulation contains 500 mg of valproic acid, which is equivalent to two 250 mg tablets.

Calculation

  • The liquid concentration is 250 mg per 5 ml 1
  • Therefore, 10 ml contains: (250 mg ÷ 5 ml) × 10 ml = 500 mg
  • Each valproic acid capsule contains 250 mg 1
  • Equivalent tablet dose: Two 250 mg capsules = 500 mg total

Bioavailability Considerations

  • All oral formulations of valproic acid (liquid, tablets, capsules) are almost completely bioavailable, approaching 100% 2, 3
  • The different formulations differ primarily in dissolution characteristics and absorption rates, not in total bioavailability 2
  • Standard immediate-release formulations have absorption half-lives of less than 30 minutes to 3-4 hours 3

Practical Conversion Guidance

When converting from liquid to tablet formulation:

  • Use a 1:1 mg-to-mg conversion (500 mg liquid = 500 mg tablet) 2
  • Maintain the same total daily dose and dosing frequency
  • Monitor for any changes in seizure control or side effects during the first 1-2 weeks after conversion
  • Consider checking valproic acid levels 3-6 months after conversion if clinically indicated 4

Important Monitoring After Conversion

  • The therapeutic range for valproic acid is 50-100 μg/mL 5, 6
  • Verify medication adherence if breakthrough seizures occur, as non-compliance is the most common cause of subtherapeutic levels 4, 7
  • Monitor liver function tests every 3-6 months, particularly in high-risk populations 4

References

Research

Clinical pharmacokinetics of valproic acid--1988.

Clinical pharmacokinetics, 1988

Guideline

Valproic Acid Safety and Efficacy in Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Valproic Acid Dosing for Impulsive Behavior

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Concentration-effect relationships of valproic acid.

Clinical pharmacokinetics, 1985

Guideline

Seizure Prevention and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.